Centers for Disease Control and Prevention. CDC COVID Data Tracker/United States Laboratory Tests. Atlanta, GA: CDC, 2020. Available at: https://covid.cdc.gov/covid-data-tracker/#testing. Accessed February5, 2020.
2.
Ewing-NelsonC.After a full month of business closures, women were hit hardest by April's job losses. Washington, DC: National Women's Law Center, 2020.
3.
BoeschD, PhadkeS. When women lose all the jobs: Essential actions for a gender-equitable recovery. Washington, DC: Center for American Progress, 2021, pp. 1–11.
4.
SonfieldA, HasstedtK, KavanaughML, AndersonR. The social and economic benefits of women’ s ability to determine whether and when to have children. New York, NY: Guttmacher Inst, 2013.
5.
LindbergLD, VandeVusseA, MuellerJ, KirsteinM. Early Impacts of the COVID-19 Pandemic: Findings from the 2020 Guttmacher Survey of Reproductive Health Experiences. New York, NY: Guttmacher Inst, 2020.
6.
MichelleH. Moniz, VanessaK. Dalton. Reimbursement for Immediate Postpartum Contraception Outside the Global Fee: Improving Outcomes and Reducing Costs for Moms and Babies. 2018.
7.
Judge-GoldenC, SmithK, MorM, BorreroS. Financial implications of 12-month dispensing of oral contraceptive pills in the veterans affairs health care system. JAMA Intern Med, 2019; 179:1201–1208.
8.
GrindlayK, GrossmanD. Prescription birth control access among U.S. women at risk of unintended pregnancy. J Womens Health (Larchmt), 2016; 25:249–254.
9.
ShotorbaniS, MillerL, BloughDK, GardnerJ. Agreement between women's and providers' assessment of hormonal contraceptive risk factors. Contraception, 2006; 73:501–506.
10.
KatzM, NewmarkRL, AronstamA, et al.An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA). Contraception, 2020; 102:392–395.